Antibiotic companies seek success by learning from each others’ failures
San Diego's Forge Therapeutics will get information from another company’s [...]
Forge achieves carb-x milestone to advance its lpxc antibiotic to treat infections caused by the world’s deadliest ‘superbugs’
-Technical milestone achievement and program advancement from initial round of [...]
Forge announces presentations at upcoming scientific and industry meetings
2018 BIO International, ASM Microbe, and GRC Metals in Medicine [...]
Forge announces oral presentation on development of novel antibiotics at the 28th annual ECCMID meeting
San Diego, California, April 9, 2018 – Forge Therapeutics, Inc. [...]
Anti-flu drug exploits weakness in H3N2 strain
More than 65,000 Americans have been victims of influenza A [...]
Antibiotic developer Forge Therapeutics expanding into new space
From about 1,000 square feet in a business incubator, antibiotic [...]
Forge Therapeutics to Present at the 2018 Needham & Company Healthcare Conference
-Presentation will focus on Forge’s portfolio of four novel classes [...]
Forge Therapeutics expands footprint in San Diego
On Monday, local leaders converged to celebrate a true San [...]
Forge Co-founder Presents New Approaches to Treat Infections at the 255th American Chemical Society National Meeting
San Diego, California, March 19, 2018 – Forge Therapeutics, Inc. [...]
Forge expands footprint with new office and lab space in Torrey Mesa, San Diego
-"What it Means to be Handcrafted in San Diego" Open [...]